BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 38428864)

  • 1. [
    Gui J; Li M; Xu J; Zhang X; Mei H; Lan X
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2308-2319. PubMed ID: 38467921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
    Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J
    Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of PET in DLBCL.
    Lewis KL; Trotman J
    Semin Hematol; 2023 Nov; 60(5):291-304. PubMed ID: 38326144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal index for detecting splenic involvement on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diffuse large B-cell lymphoma.
    Kozuki R; Sugimoto T; Goto H; Miyamoto N; Hirakawa Y; Umeno A; Idei M; Tagawa S; Namba F; Tani R; Ohmori M; Hamanaka A; Adachi S; Tomita M
    Medicine (Baltimore); 2024 Mar; 103(9):e37290. PubMed ID: 38428864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Liver and Tumor [
    Wu X; Bhattarai A; Korkola P; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    Mol Imaging Biol; 2017 Oct; 19(5):787-794. PubMed ID: 28144908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
    Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M
    Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype Differentiation.
    Enke JS; Moltz JH; D'Anastasi M; Kunz WG; Schmidt C; Maurus S; Mühlberg A; Katzmann A; Sühling M; Hahn H; Nörenberg D; Huber T
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Harder FN; Jungmann F; Kaissis GA; Lohöfer FK; Ziegelmayer S; Havel D; Quante M; Reichert M; Schmid RM; Demir IE; Friess H; Wildgruber M; Siveke J; Muckenhuber A; Steiger K; Weichert W; Rauscher I; Eiber M; Makowski MR; Braren RF
    EJNMMI Res; 2021 Jul; 11(1):70. PubMed ID: 34322781
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hu Y; Zhou W; Sun S; Guan Y; Ma J; Xie Y
    Ann Transl Med; 2021 Jun; 9(12):1009. PubMed ID: 34277809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severity.
    Seong H; Jeong YH; Lee WJ; Kim JH; Kim JH; Ahn JY; Jeong SJ; Choi JY; Park YS; Yeom JS; Song YG; Cho A; Ku NS
    Sci Rep; 2021 May; 11(1):10836. PubMed ID: 34035381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
    Shen R; Xu PP; Wang N; Yi HM; Dong L; Fu D; Huang JY; Huang HY; Janin A; Cheng S; Wang L; Zhao WL
    Clin Transl Med; 2020 Nov; 10(7):e221. PubMed ID: 33252851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma.
    Baek DW; Cho HJ; Kim JH; Sohn SK; Song GY; Ahn SY; Jung SH; Ahn JS; Lee JJ; Kim HJ; Jeong SY; Hong CM; Min JJ; Moon JH; Yang DH
    In Vivo; 2020; 34(4):2127-2134. PubMed ID: 32606193
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.